Morning Trend | China Life (2628.HK) Golden Cross, Weighted Blue Chips Receive Capital Resonance Again

China Life (2628.HK) performed steadily during yesterday's trading session, with a moderate increase in volume and a continuous orderly inflow of funds throughout the day. Recently, the life insurance sector has gained market attention, primarily due to the "New Year Red" premium boost and frequent regulatory benefits, leading to an overall positive performance expectation for the industry. China Life's stock price has consistently remained above the 5-day and 10-day moving averages, with K-line segments trending upward. The main funds in the market have significantly driven the sector's individual stocks, and afternoon northbound funds continued to flow in, steadily pushing the stock price to reach a phase high. Further loosening of insurance investment policies has acted as a catalyst, with several insurance institutions announcing plans to expand equity investments. The market generally expects the industry's risk appetite to gradually warm up. Continuous positive policy releases have heightened expectations for blue-chip valuation recovery, making weighted assets the main focus for short-term capital intervention. However, there has been some profit-taking at high levels in the intraday trend, raising the risk of switching hotspots between sectors. Looking back at the technical aspects, the moving average system provides support, and the volume has moderately increased, solidifying the overall bullish structure. In the short term, attention should still be paid to fund flows and transaction changes. If the macro environment does not experience significant fluctuations, the trend of weighted blue chips is unlikely to reverse. Keep an eye on industry dynamics and the pace of company announcements to guard against unexpected risk releases that could lead to sector adjustments